(Q37426526)

20 August 2017

1 reference

title

Clonazepam as a therapeutic adjunct to improve the management of depression: a brief review (English)

1 reference

20 August 2017

Shigeru Morishita

1

1 reference

20 August 2017

publication date

1 April 2009

1 reference

20 August 2017

published in

Human Psychopharmacology

1 reference

20 August 2017

volume

24

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

191-198

1 reference

20 August 2017

1 reference

Lithium Response in Unipolar Versus Bipolar Depression

21 January 2018

1 reference

Altered 5-HT metabolism with clonazepam, diazepam and diphenylhydantoin

21 January 2018

1 reference

Treatment resistant depression in a case of minor head injury: an electrophysiological hypothesis

21 January 2018

1 reference

Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study

21 January 2018

1 reference

Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder

21 January 2018

1 reference

Non-monoamine-based approach for the treatment of depression and anxiety disorders

21 January 2018

1 reference

7 January 2021

Antiepileptic drug augmentation for treatment-resistant depression

1 reference

7 January 2021

Clonazepam: a novel therapeutic adjunct

1 reference

7 January 2021

Clonazepam--antipsychotic effect in a case of schizophrenia-like psychosis with epilepsy and in three cases of atypical psychosis

1 reference

7 January 2021

Early coadministration of clonazepam with sertraline for panic disorder

1 reference

7 January 2021

Ethopharmacology of the antidepressant effect of clonazepam in diabetic rats

1 reference

7 January 2021

Clonazepam suppresses GABAB-mediated inhibition in thalamic relay neurons through effects in nucleus reticularis

1 reference

7 January 2021

Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosus

1 reference

7 January 2021

The classification of depressions and the activity profile of the antidepressants

1 reference

7 January 2021

Treatment of depression with clonazepam

1 reference

7 January 2021

Early- versus late-onset dysthymic disorder: comparison in out-patients with superimposed major depressive episodes

1 reference

7 January 2021

Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response

1 reference

7 January 2021

Pharmacokinetic and Pharmacodynamic Interactions of Oral Midazolam with Ketoconazole, Fluoxetine, Fluvoxamine, and Nefazodone

1 reference

7 January 2021

Pharmacomanometric Studies of Colonic Motility as a Guide to the Chemotherapy of Schizophrenia

1 reference

7 January 2021

Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression

1 reference

7 January 2021

Case of bipolar disorder successfully stabilized with clonazepam, valproate and lithium after numerous relapses for 47 years

1 reference

7 January 2021

Clonazepam in the treatment of prolonged depression

1 reference

7 January 2021

Clonazepam augmentation of antidepressants: does it distinguish unipolar from bipolar depression?

1 reference

7 January 2021

Clonazepam as a therapeutic adjunct to improve the management of psychiatric disorders

1 reference

7 January 2021

Possible predictors of response to clonazepam augmentation therapy in patients with protracted depression

1 reference

7 January 2021

Clonazepam in the treatment of psychiatric disorders: an update

1 reference

7 January 2021

Clinical and differential diagnostic aspects of treatment-resistant depression

1 reference

7 January 2021

GABA and mood disorders: a brief review and hypothesis

1 reference

7 January 2021

A case of "double" depression under outpatient treatment conditions

1 reference

7 January 2021

1 reference

7 January 2021

Recovery from neuroendocrinological abnormalities and frontal hypoperfusion after remission in a case with rapid cycling bipolar disorder.

1 reference

7 January 2021

GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent.

1 reference

7 January 2021

Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?

1 reference

7 January 2021

Clonazepam augmentation therapy in a male at early adolescence with rapid cycling bipolar disorder

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.1015

1 reference

20 August 2017

1 reference